12

Mar

Sanofi, Translate Bio launch human trial of mRNA COVID-19 vaccine

Sanofi and Translate Bio said on Friday they had started a human trial of their mRNA COVID-19 vaccine candidate, the French drugmaker’s second vaccine project, which follows a protein-based shot…

Read More Here

22

Feb

GSK, Sanofi begin new COVID-19 vaccine trial of protein-based vaccine

Britain's GlaxoSmithKline and France's Sanofi on Monday said they had started a new clinical trial of their protein-based COVID-19 vaccine candidate and aim to reach the final testing stage in…

Read More Here

14

Feb

Sanofi’s mRNA COVID-19 vaccine candidate will not be ready this year

A COVID-19 vaccine candidate developed by Sanofi and U.S. group Translate Bio "will not be ready this year," the French drugmaker's chief executive told Le Journal du Dimanche newspaper. Clinical…

Read More Here

27

Jan

Sanofi confirms its will supply over 125 millions Pfizer-BioNTech doses to the EU

PARIS, Jan 27 (Reuters) - French pharmaceutical giant Sanofi said on Wednesday it had struck an agreement with Germany's BioNTech to supply the European Union with the company's vaccine developed…

Read More Here

18

Jan

Sanofi to cut around 400 job positions in pharma research

French healthcare company Sanofi has told trade unions that it is planning to cut around 400 job positions in its pharmaceutical research division, France Inter reported on Monday. In June…

Read More Here

05

Sep

Future COVID-19 vaccine seen below 10 euros – Sanofi

Sanofi's chief in France, Olivier Bogillot, said on Saturday that its future COVID-19 vaccine was likely to be priced below 10 euros per shot. "The price is not totally set…

Read More Here

02

Sep

Sanofi says Kevzara drug fails as possible COVID-19 treatment

The rheumatoid arthritis drug Kevzara has failed as a COVID-19 treatment, French drugmaker Sanofi announced following a similar flop of a Roche product. Sanofi said Kevzara - which it produces…

Read More Here

26

Jun

Sanofi considering up to 1,680 job cuts in Europe

Sanofi is considering cutting up to 1,680 jobs in Europe, two sources familiar with the matter said on Friday, as the French drugmaker outlined plans to reduce costs to staff…

Read More Here

14

May

Sanofi to accelerate European COVID-19 vaccine access after CEO prioritizes U.S. preorders

  French drugmaker Sanofi SA said on Wednesday that it is working with European regulators to speed up access to a potential coronavirus vaccine in Europe after its chief executive…

Read More Here

14

May

Sanofi to give US preference on future Covid-19 vaccine

The US will have priority access to a Covid-19 vaccine if and when Sanofi develops one, the French pharmaceutical giant told Bloomberg, explaining that the US offered more money to…

Read More Here

11

Apr

Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries

  As of Friday, Sanofi has committed to donating 100 million doses of hydroxychloroquine to 50 countries around the world and has begun to progressively deliver the medicine to authorities…

Read More Here

09

Dec

France’s Sanofi to buy Synthorx for $2.5 billion

France’s Sanofi said on Monday it had agreed to buy Synthorx in a cash deal worth around $2.5 billion as it seeks to beef up its immuno-oncology pipeline. Under the…

Read More Here

30

Sep

French drugmaker Sanofi to cut around 200 jobs in Japan

French drugmaker Sanofi SA plans to cut around 200 jobs in Japan across sales, regulatory affairs and operations, a person familiar with the matter said, months after the company said…

Read More Here